FDA Drug Application (201616) for HYDROCHLOROTHIAZIDE; IRBESARTAN by CIPLA LIMITED

Back to FDA Applications sponsored by CIPLA LIMITED

Application Number201616
Product Number001
FormTABLET; ORAL
Dosage12.5MG; 150MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameHYDROCHLOROTHIAZIDE; IRBESARTAN
Active IngredientHYDROCHLOROTHIAZIDE; IRBESARTAN



Back to FDA Applications sponsored by CIPLA LIMITED

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.